Pulmonary Drug Delivery Technologies - A Global Market Perspective : Market Research Report

Pulmonary Drug Delivery Technologies - A Global Market Perspective

Published: Nov. 1, 2009 - 165 Pages

1. METHODOLOGY: Study Reliability and Reporting Limitations; Disclaimers; Quantitative Techniques & Reporting Level
2. MARKET DYNAMICS: Market Overview; Pulmonary Devices: Gaining Pace; Market Highlights; Primary Position of the US; Pulmonary Drug Delivery: An Attractive Non-Invasive Option; Chief Pulmonary Delivery Technologies; Most Effective Route for Respiratory Syndromes; The Attractiveness of Inhalers; Choice of Drug Delivery System; Inhalation Therapy: A Retrospection; Pulmonary Drug Delivery - Market Snapshots
3. TRENDS AND ISSUES: Market Snippets; Focus of New Age Pulmonary Devices; Dry Powder Inhalation: A Promising Technology; Research Activities in Inhaled Drug Delivery; Lung Versus Oropharyngeal Deposition: A Major Challenge; Competitive Environment; Inefficient Use of Pulmonary Drug Delivery Systems; Issues Facing Various Inhalation Devices
4. GROWTH DRIVERS: Growth Drivers in Pulmonary Drug Delivery; Use of Nanotechnology in Drug Delivery Products; Other Growth Areas; Innovative Pulmonary Devices Shape Progress; Pulmonary Insulin; Alternative Drug Delivery Systems: A Review; Inhaled Small Molecule Therapeutics
5. PRODUCT FACTS: Metered Dose Inhalers (MDIs); Dry Powder Inhalers (DPIs); Nebulizers
6. REGULATORY ENVIRONMENT: The Montreal Protocol; FDA Bans the Use of CFC’s in Metered Dose Inhalers
7. CORPORATE DEVELOPMENTS: Sepracor Signs Agreement with Nycomed; Kamada Enter into Strategic Pacts with Pari Pharma; GlaxoSmithKline Ties-Up with Amira Pharmaceuticals; Consort Medical Releases Meter Dose Inhalers; Trinity Chiesi Pharmaceuticals Introduces Fostair; BattellePharma Takes Over Ventaira Pharmaceuticals; Eurand Takes Over SourceCF; Aradigm Signs Agreement with Lung Rx forDeveloping AERx Essence(R)- Technology; Vectura Inks Agreement with a European Company; ZYFLO CR™ Obtains FDA Clearance; SkyePharma Revises Agreement with Abott; Alnylam Presents Scientific Progress of ALN-RSV01; Bayer HealthCare and Nektar Therapeutics to Develop NKTR-061; AstraZeneca Launches Symbicort®; Dey, L.P Unveils Perforomist™; Next Safety Rolls Out Hi-Performance Drug Delivery Technology
8. MAJOR PLAYERS: 3M Drug Delivery Systems Division (USA); Akela Pharma Inc (Canada); Alkermes, Inc. (USA); Aradigm Corporation (USA); AstraZeneca Plc (UK); Baxter Healthcare Corporation (USA); Chiesi Farmaceutici SpA (Italy); Consort Medical Plc (UK); Dey L.P. (USA); GlaxoSmithKline Plc (UK); Graceway Pharmaceuticals, LLC (USA); Nektar Therapeutics (USA); Oriel Therapeutics, Inc. (USA); Sepracor, Inc. (USA); SkyePharma Plc (UK); Vectura Group Plc (UK)
9. GLOBAL MARKET ANALYTICS
10. THE UNITED STATES: Forecast for the Near Future; New Age Pulmonary Drug Delivery Technologies; Drug Delivery Market in the US
11. CANADA
12. JAPAN: Market Overview; Market Highlights
13. EUROPE: a.France; b.Germany; c.The United Kingdom; d.Italy; e.Spain; f.Russia; g.Rest of Europe
14. ASIA-PACIFIC: China; India; Australia
15. LATIN AMERICA: Brazil
16. REST OF WORLD: Table 1: Percentage Breakdown of Major Brands in the Global Market for Inhaled Drug Delivery Systems - 2004; Table 2: Percentage Breakdown of World Market for Pulmonary Drug Delivery Technologies by Drug Category - 2005; Table 3: Global Pulmonary Drug Delivery Technologies Market by Region for the Period 2007-2015 (Sales in US$ Million); Table 4: Percentage Breakdown of Global Pulmonary Drug Delivery Technologies Market by Region for the Years 2008 & 2012; Table 5: Global Metered Dose Inhalers (MDIs) Market by Region for the Period 2007-2015 (Sales in US$ Million); Table 6: Percentage Breakdown of Global Metered Dose Inhalers (MDIs) Market by Region for the Years 2008 & 2012; Table 7: Global Dry Powder Inhalers (DPIs) Market by Region for the Period 2007-2015 (Sales in US$ Million); Table 8: Percentage Breakdown of Global Dry Powder Inhalers (DPIs) Market by Region for the Years 2008 & 2012; Table 9: Global Nebulizers Market by Region for the Period 2007-2015 (Sales in US$ Million); Table 10: Percentage Breakdown of Global Nebulizers Market by Region for the Years 2008 & 2012; Table 11: Percentage Breakdown of US Market for Pulmonary Drug Delivery Technologies by Application Area - 2010P; Table 12: Percentage Breakdown of the Non-CFC Metered Dose Inhalers Market by Application Areas in the US - 2010; Table 13: Percentage Breakdown of Non-CFC Metered Dose Inhalers Primary Manufacturers in the US - 2004; Table 14: Percentage Breakdown of Leading Dry Powder Inhalers Manufacturers in the US - 2004; Table 15: Percentage Breakdown of Dry Powder Inhalers by Application Areas in the US - 2010; Table 16: Pulmonary Drug Delivery Technologies Market by Product Segment in the US: 2007-2015 (Sales in US$ Million); Table 17: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in the US for the Years 2008 & 2012; Table 18: Pulmonary Drug Delivery Technologies Market by Product Segment in Canada: 2007-2015 (Sales in US$ Million); Table 19: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in Canada for the Years 2008 & 2012; Table 20: Percentage Breakdown of Leading Pulmonary Drug Delivery Systems Brands in Japan - 2004; Table 21: Pulmonary Drug Delivery Technologies Market by Product Segment in Japan: 2007-2015 (Sales in US$ Million); Table 22: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in Japan for the Years 2008 & 2012; Table 23: Pulmonary Drug Delivery Technologies Market by Region in Europe: 2007-2015 (Sales in US$ Million); Table 24: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Region in Europe for the Years 2008 & 2012; Table 25: Pulmonary Drug Delivery Technologies Market by Product Segment in Europe: 2007-2015 (Sales in US$ Million); Table 26: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in Europe for the Years 2008 & 2012; Table 27: Pulmonary Drug Delivery Technologies Market by Product Segment in France: 2007-2015 (Sales in US$ Million); Table 28: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in France for the Years 2008 & 2012; Table 29: Pulmonary Drug Delivery Technologies Market by Product Segment in Germany: 2007-2015 (Sales in US$ Million); Table 30: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in Germany for the Years 2008 & 2012; Table 31: Percentage Breakdown of by Major Brands in the UK Market for Inhaled Drug Delivery Systems - 2004; Table 32: Pulmonary Drug Delivery Technologies Market by Product Segment in the UK: 2007-2015 (Sales in US$ Million); Table 33: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in the UK for the Years 2008 & 2012; Table 34: Percentage Breakdown of Major Pulmonary Drug Delivery Systems Brands in Italy - 2004; Table 35: Pulmonary Drug Delivery Technologies Market by Product Segment in Italy: 2007-2015 (Sales in US$ Million); Table 36: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in Italy for the Years 2008 & 2012; Table 37: Percentage Breakdown of Leading Pulmonary Drug Delivery Systems Brands in Spain - 2004; Table 38: Pulmonary Drug Delivery Technologies Market by Product Segment in Spain: 2007-2015 (Sales in US$ Million); Table 39: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in Spain for the Years 2008 & 2012; Table 40: Pulmonary Drug Delivery Technologies Market by Product Segment in Russia: 2007-2015 (Sales in US$ Million); Table 41: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in Russia for the Years 2008 & 2012; Table 42: Pulmonary Drug Delivery Technologies Market by Product Segment in Rest of Europe: 2007-2015 (Sales in US$ Million); Table 43: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in Rest of Europe for the Years 2008 & 2012; Table 44: Pulmonary Drug Delivery Technologies Market by Product Segment in Asia-Pacific: 2007-2015 (Sales in US$ Million); Table 45: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in Asia-Pacific for the Years 2008 & 2012; Table 46: Pulmonary Drug Delivery Technologies Market by Product Segment in Latin America: 2007-2015 (Sales in US$ Million); Table 47: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in Latin America for the Years 2008 & 2012; Table 48: Pulmonary Drug Delivery Technologies Market by Product Segment in Rest of World: 2007-2015 (Sales in US$ Million); Table 49: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in Rest of World for the Years 2008 & 2012
COMPANIES PROFILED

Abstract

Until recent years, respiratory conditions such as asthma, chronic obstructive pulmonary, and emphysema disease represented the sole therapeutic areas of the pulmonary sector. However, recent technological advancements have spanned the application of pulmonary devices to the treatment of non-respiratory conditions such diabetes, migraine. The attractiveness of pulmonary delivery of drugs for the treatment of respiratory diseases stems from the fact that topical drug deposition to infected lung gives a fast therapeutic effect and reduces side effects associated with key drugs.

Advancements in formulating technology are expected to push sales of dry powder inhalers replacing metered-dose inhalers to a larger extent. Dry powder inhalation (DPI), an enabling concept in the noninvasive drug delivery, is progressively emerging as important contender among pulmonary drug delivery methods. This importance is being fueled by latest developments including sophisticated device architectures, growing research activity in powder formulations, and innovations in particle engineering.

These and other market data and trends are presented in "Pulmonary Drug Delivery Technologies: A Global Market Perspective" by BizAcumen LLC. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

Get Full Details About This Report >>

US: 800.298.5699

Int'l: +1.240.747.3093

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 300,000 market research reports, company profiles and country profiles from over 700 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

2/15/2012 - 31

Pulmonary Drug Delivery Technologies - A Global Market Perspective

Table of Contents

Abstract